Boston, United States
Xontogeny is a pioneering biotech aggregator founded in 2016, with a unique approach to advancing life science technologies aimed at treating serious diseases. The company stands apart through its model of partnering with entrepreneurs to provide the essential leadership and operational expertise for enhancing success rates in early-stage drug and technology development.
Complementing the scientific passion of founders, Xontogeny's seasoned team optimizes development pathways, facilitating the sustained growth of affiliated startups while maintaining efficiency and minimizing costs. This strategy not only aids entrepreneurs in maintaining greater control and equity but also amplifies their prospects for investment and developmental achievements.
Headquartered in the United States, Xontogeny operates mainly within the Biopharma, Biotechnology, Health Care, and Information Technology sectors. The firm's most recent financing involved a $15 million Series A investment on May 18, 2017, led by Perceptive Advisors, underscoring investor confidence in its innovative approach.
